Single-strand mismatch and damage patterns revealed by single-molecule DNA sequencing.
Biorxiv : The Preprint Server For Biology
Liu, Mei Hong MH; Costa, Benjamin B; Choi, Una U; Bandler, Rachel C RC; Lassen, Emilie E; Grońska-Pęski, Marta M; Schwing, Adam A; Murphy, Zachary R ZR; Rosenkjær, Daniel D; Picciotto, Shany S; Bianchi, Vanessa V; Stengs, Lucie L; Edwards, Melissa M; Loh, Caitlin A CA; Truong, Tina K TK; Brand, Randall E RE; Pastinen, Tomi T; Wagner, J Richard JR; Skytte, Anne-Bine AB; Tabori, Uri U; Shoag, Jonathan E JE; Evrony, Gilad D GD
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer.
Esmo Open
Koppikar, S S; Oaknin, A A; Babu, K Govind KG; Lorusso, D D; Gupta, S S; Wu, L-Y LY; Rajabto, W W; Harano, K K; Hong, S-H SH; Malik, R A RA; Strebel, H H; Aggarwal, I M IM; Lai, C-H CH; Dejthevaporn, T T; Tangjitgamol, S S; Cheng, W F WF; Chay, W Y WY; Benavides, D D; Hashim, N M NM; Moon, Y W YW; Yunokawa, M M; Anggraeni, T D TD; Wei, W W; Curigliano, G G; Maheshwari, A A; Mahantshetty, U U; Sheshadri, S S; Peters, S S; Yoshino, T T; Pentheroudakis, G G
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT).
Pathologic complete response to immune checkpoint inhibitor in a stage IIIB ovarian clear cell carcinoma patient with POLE mutation resistant to platinum-based chemotherapy: a case report.
Gland Surgery
Li, Shuzhan S; Zhang, Jiali J; Du, Weijiao W; Ren, Xiubao X; Zhang, Xinwei X
Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1.
International Journal Of Molecular Sciences
Mitiushkina, Natalia V NV; Yanus, Grigory A GA; Kuligina, Ekatherina Sh ES; Laidus, Tatiana A TA; Romanko, Alexandr A AA; Kholmatov, Maksim M MM; Ivantsov, Alexandr O AO; Aleksakhina, Svetlana N SN; Imyanitov, Evgeny N EN
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers.
Jco Precision Oncology
Garmezy, Benjamin B; Gheeya, Jinesh J; Lin, Heather Y HY; Huang, Yuefan Y; Kim, Taebeom T; Jiang, Xianli X; Thein, Kyaw Z KZ; Pilié, Patrick G PG; Zeineddine, Fadl F; Wang, Wanlin W; Shaw, Kenna R KR; Rodon, Jordi J; Shen, John Paul JP; Yuan, Ying Y; Meric-Bernstam, Funda F; Chen, Ken K; Yap, Timothy A TA
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers.
Jco Precision Oncology
Garmezy, Benjamin B; Gheeya, Jinesh J; Lin, Heather Y HY; Huang, Yuefan Y; Kim, Taebeom T; Jiang, Xianli X; Thein, Kyaw Z KZ; Pilié, Patrick G PG; Zeineddine, Fadl F; Wang, Wanlin W; Shaw, Kenna R KR; Rodon, Jordi J; Shen, John Paul JP; Yuan, Ying Y; Meric-Bernstam, Funda F; Chen, Ken K; Yap, Timothy A TA
A radiogenomics application for prognostic profiling of endometrial cancer.
Communications Biology
Hoivik, Erling A EA; Hodneland, Erlend E; Dybvik, Julie A JA; Wagner-Larsen, Kari S KS; Fasmer, Kristine E KE; Berg, Hege F HF; Halle, Mari K MK; Haldorsen, Ingfrid S IS; Krakstad, Camilla C
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.
Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants.
Gynecologic Oncology Reports
Villy, M-C MC; Masliah-Planchon, J J; Melaabi, S S; Trabelsi Grati, O O; Girard, E E; Bataillon, G G; Vincent-Salomon, A A; Le Gall, J J; Golmard, L L; Stoppa-Lyonnet, D D; Bieche, I I; Colas, C C
Publication Date: 2021-08
Variant appearance in text: POLE: 890C>T; Ser297Phe
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment.
Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencing.
Bmc Medical Genomics
Davila, Jaime I JI; Chanana, Pritha P; Sarangi, Vivekananda V; Fogarty, Zachary C ZC; Weroha, S John SJ; Guo, Ruifeng R; Goode, Ellen L EL; Huang, Yajue Y; Wang, Chen C
Combination of Proactive Molecular Risk Classifier for Endometrial cancer (ProMisE) with sonographic and demographic characteristics in preoperative prediction of recurrence or progression of endometrial cancer.
Ultrasound In Obstetrics & Gynecology : The Official Journal Of The International Society Of Ultrasound In Obstetrics And Gynecology
Eriksson, L S E LSE; Nastic, D D; Lindqvist, P G PG; Imboden, S S; Järnbert-Pettersson, H H; Carlson, J W JW; Epstein, E E
Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome.
Nature Communications
Hollis, Robert L RL; Thomson, John P JP; Stanley, Barbara B; Churchman, Michael M; Meynert, Alison M AM; Rye, Tzyvia T; Bartos, Clare C; Iida, Yasushi Y; Croy, Ian I; Mackean, Melanie M; Nussey, Fiona F; Okamoto, Aikou A; Semple, Colin A CA; Gourley, Charlie C; Herrington, C Simon CS